SM

Santosh Maharudrappa Indure

Active Director Designated Partner DIN 10100455
DIN 10100455 First appointment May 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Maharudrappa Indure

Data last updated:

Santosh Maharudrappa Indure is a Designated Partner at Irestore Lifescience Technology Llp (since 2023). The company operates in Healthcare.

DIN 10100455
Primary Designation Designated Partner
Industry Healthcare
First Appointment 03 May 2023
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 May 20232021Active

Board colleagues of Santosh Maharudrappa Indure

Directorship timeline

Open interactive timeline →
Irestore Lifescience Technology Llp
Premium access

Shareholding and investment profile for Santosh Maharudrappa Indure

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Maharudrappa Indure

Santosh Maharudrappa Indure currently holds 1 directorship: Irestore Lifescience Technology Llp (Designated Partner, since 03 May 2023).

Santosh Maharudrappa Indure was first appointed on 03 May 2023 as Designated Partner at Irestore Lifescience Technology Llp.

The current boards of Santosh Maharudrappa Indure's companies include Anjalee Santosh Indure (Irestore Lifescience Technology Llp), Jignesh Jamnadas Uteshiya (Irestore Lifescience Technology Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available